ABVC BioPharma, Inc. (ABVC)
0.8444
-0.08
(-8.22%)
USD |
NASDAQ |
Aug 24, 16:00
0.8444
0.00 (0.00%)
After-Hours: 19:58
ABVC BioPharma Price to Book Value : 2.115 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 2.304 |
| August 20, 2026 | 2.304 |
| August 19, 2026 | 2.425 |
| August 18, 2026 | 2.243 |
| August 17, 2026 | 2.201 |
| August 14, 2026 | 2.330 |
| August 13, 2026 | 2.484 |
| August 12, 2026 | 2.486 |
| August 11, 2026 | 2.551 |
| August 10, 2026 | 2.460 |
| August 07, 2026 | 2.641 |
| August 06, 2026 | 2.641 |
| August 05, 2026 | 2.615 |
| August 04, 2026 | 2.771 |
| August 03, 2026 | 2.693 |
| July 31, 2026 | 2.615 |
| July 30, 2026 | 2.797 |
| July 29, 2026 | 2.615 |
| July 28, 2026 | 2.745 |
| July 27, 2026 | 2.641 |
| July 24, 2026 | 2.978 |
| July 23, 2026 | 3.108 |
| July 22, 2026 | 3.056 |
| July 21, 2026 | 3.185 |
| July 20, 2026 | 3.108 |
| Date | Value |
|---|---|
| July 17, 2026 | 3.237 |
| July 16, 2026 | 3.133 |
| July 15, 2026 | 3.315 |
| July 14, 2026 | 3.47 |
| July 13, 2026 | 3.496 |
| July 10, 2026 | 3.910 |
| July 09, 2026 | 3.755 |
| July 08, 2026 | 5.231 |
| July 07, 2026 | 5.231 |
| July 06, 2026 | 4.920 |
| July 02, 2026 | 4.661 |
| July 01, 2026 | 4.584 |
| June 30, 2026 | 4.092 |
| June 29, 2026 | 3.882 |
| June 26, 2026 | 3.784 |
| June 25, 2026 | 3.586 |
| June 24, 2026 | 3.289 |
| June 23, 2026 | 3.240 |
| June 22, 2026 | 3.264 |
| June 18, 2026 | 3.338 |
| June 17, 2026 | 3.363 |
| June 16, 2026 | 3.190 |
| June 15, 2026 | 3.116 |
| June 12, 2026 | 2.943 |
| June 11, 2026 | 3.240 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Anika Therapeutics, Inc. | 2.077 |
| Perspective Therapeutics, Inc. | 1.120 |
| MiMedx Group, Inc. | 2.887 |
| Abbott Laboratories | 3.950 |
| AngioDynamics, Inc. | 3.852 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0684 |
| Price | 0.8444 |
| Earnings Yield | -34.08% |
| Market Cap | 21.76M |
| PEGY Ratio | -0.0684 |